Press releases
- 10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
- 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
- 10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
- 10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
- 10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
- 10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology
- 10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
- 10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
More ▼
Key statistics
On Thursday, 10X Genomics Inc (1KJ:FRA) closed at 35.07, 9.87% above its 52-week low of 31.92, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 33.59 |
---|---|
High | 35.07 |
Low | 33.59 |
Bid | -- |
Offer | -- |
Previous close | 31.97 |
Average volume | 465.67 |
---|---|
Shares outstanding | 119.17m |
Free float | 101.03m |
P/E (TTM) | -- |
Market cap | 4.40bn USD |
EPS (TTM) | -2.18 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 15:51 BST.
More ▼